Social Anxiety Disorder Clinical Trial
Official title:
Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders With Adults: Manual Development and Randomized-Controled Feasibility Study
Verified date | October 2019 |
Source | Heidelberg University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Goals of the study:
Systemic Therapy was approved in 2008 by the Scientific Advisory Board on Psychotherapy
(Wissenschaftlicher Beirat Psychotherapie: WBP) for a variety of disorders which, at the
time, did not include anxiety disorders. According to the 2007 joint methods paper of the WBP
and the Mutual Federal Committee (Gemeinsamen Bundesausschuss: G-Ba), there must be three
randomized-controlled trials (RCT) for anxiety disorders. These studies are available now but
lack explicit details about the clinical significance of the reductions they show in social
anxiety symptoms. This project is funded by the German Association for Systemic Therapy,
Counseling and Family Therapy (Deutsche Gesellschaft für Systemische Therapie, Beratung und
Familientherapie: DGSF).
Study design:
The study is planned as a mono-centric, balanced pilot RCT. It investigates the feasibility
of an RCT comparing Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety
Disorders (SAD) in 32 patients.
Status | Completed |
Enrollment | 38 |
Est. completion date | September 2017 |
Est. primary completion date | January 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Social Anxiety Disorder (SKID: ICD-Diagnosis: F40.1, Liebowitz Social Anxiety Scale > 30); - Agreement to participate in the study and to be randomized into the two treatment groups Exclusion Criteria: - Acute drug or alcohol intoxication or dependency - Anorexia with BMI < 14 - Psychotic disorder - Severe physical diseases |
Country | Name | City | State |
---|---|---|---|
Germany | Institute of Medical Psychology, University Hospital Heidelberg | Heidelberg | Baden-Württemberg |
Lead Sponsor | Collaborator |
---|---|
Heidelberg University | German Association for Systemic Therapy, Counseling and Family Therapy (DGSF), Heidehof Foundation, Systemic Society (SG) |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of Liebowitz Social Anxiety Scale (LSAS-SR) | Social Anxiety will be assessed using the Liebowitz Social Anxiety Scale (LSAS-SR) in its German version. The LSAS-SR is a brief 24-item self report instrument with 13 items relating to performance anxiety and 11 concerning social situations. Its purpose is to assess the range of social interaction and performance situations feared and the degree of avoidance by a patient in order to assist in the diagnosis of social anxiety disorder, 24 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Primary | Change of Social Interaction Anxiety Scale (SIAS) | Measure of social interaction anxiety, 20 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Primary | Change of Social Phobia Scale (SPS) | Measure of anxiety while being observed by others, 20 items, German version | Baseline, 8th,15th and 20th hour of therapy, end of treatment; 6, 9 and 12 months after randomization | |
Secondary | Change of Adjustment to Symptomatology Scale (ASS) | Measure of adjustment to the symptomatology, 5 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of Evaluation of Social Systems (EVOS) | Measure of social relationships in different social systems, 10 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of Experience in Social Systems (EXIS) | Measure of the individual experience in different social systems, 24 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of Beck Depression Inventory-II (BDI-II) | Severity of depressive symptoms "at that moment", specifically assessing the intensity of depression in psychiatric and normal populations, 21 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of Brief Symptom Checklist (BSCL) | The instrument provides an overview of a patient's symptoms and their intensity at a specific point in time, 53 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of Inventory of Interpersonal Problems (IIP-32) | The IIP-32 is a self-report instrument that identifies a person's most salient interpersonal difficulties. It is a short version of the Inventory of Interpersonal Problems, 32 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of Dyadic Adjustment Scale (DAS-12) | Measure of relationship adjustment, 12 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of University of Rhode Island Change Assessment (URICA-S, short version) | Measure of stages of change, 16 items, German version | Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization | |
Secondary | Change of Burden Assessment Scale (BAS) | Measure of perceived burden in daily life among resource persons, 19 items, German version | Baseline, 26th hour of therapy; 12 months after randomization | |
Secondary | Change of Scale for the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (SACiP), | Measure of the six dimensions of resource activation, problem actuation, mastery, clarification of meaning, emotional bond, agreement on collaboration, 21 items, German version | 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06274112 -
Using TMS to Understand Neural Processes of Social Motivation
|
N/A | |
Completed |
NCT02554929 -
Treatment of Social Anxiety Disorder and Selective Mutism
|
N/A | |
Completed |
NCT00684541 -
Interpretation Modification Program for Social Phobia
|
N/A | |
Completed |
NCT00684320 -
Attention Disengagement Training for Social Phobia
|
N/A | |
Completed |
NCT03247075 -
Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT
|
N/A | |
Completed |
NCT02811458 -
Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders
|
N/A | |
Withdrawn |
NCT04622930 -
Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD)
|
N/A | |
Active, not recruiting |
NCT05018312 -
Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety
|
N/A | |
Active, not recruiting |
NCT05124639 -
Clinical Trial of a Group Self-management Support Program for Anxiety Disorders
|
N/A | |
Completed |
NCT05858294 -
The Safety, Acceptability and Efficacy of Alena
|
N/A | |
Active, not recruiting |
NCT05600114 -
Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Not yet recruiting |
NCT02924610 -
Brief Intervention to Reduce Fear
|
Phase 4 | |
Active, not recruiting |
NCT02592564 -
Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder
|
N/A | |
Recruiting |
NCT02305537 -
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
|
N/A | |
Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
Unknown status |
NCT01712321 -
Study of Vilazodone to Treat Social Anxiety Disorder
|
N/A | |
Completed |
NCT01320800 -
CBT for Social Anxiety Disorder Delivered by School Counselors
|
Phase 2 | |
Completed |
NCT00485615 -
An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
|
Phase 2 | |
Completed |
NCT00773162 -
Flushing in Social Anxiety Disorder on Seroquel
|
Phase 3 |